Aethlon Medical, Inc. (NASDAQ:AEMD) Sees Large Growth in Short Interest

Aethlon Medical, Inc. (NASDAQ:AEMD) saw a large growth in short interest in January. As of January 15th, there was short interest totalling 1,190,000 shares, a growth of 201.5% from the December 31st total of 394,700 shares. Based on an average daily trading volume, of 3,000,000 shares, the days-to-cover ratio is currently 0.4 days.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the stock. StockNews.com began coverage on shares of Aethlon Medical in a research note on Monday. They set a “sell” rating on the stock. HC Wainwright restated a “buy” rating and set a $7.00 price objective on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Price Performance

AEMD stock opened at $0.74 on Thursday. Aethlon Medical has a 1 year low of $0.24 and a 1 year high of $1.88. The company has a market cap of $10.35 million, a P/E ratio of -0.26 and a beta of 1.61. The stock’s fifty day moving average price is $0.56 and its 200-day moving average price is $0.45.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.